Natural Pain Relief Center

Natural Pain Relief Center is a healthcare and research organization that developed a proprietary, non-narcotic protocol for the treatment of chronic pain. Led by CEO Paul Anderson, MD, the company's approach focuses on restoring the body's endogenous opioid system through a combination of D-phenylalanine (DPA), microelectric current, and nutritional supplementation. The protocol works by inhibiting enzymes such as carboxypeptidase A and enkephalinase, which are responsible for the degradation of natural endorphins. In 2008, the company's North American licensing rights were acquired by Innolife Pharma Inc., with plans to implement the treatment across a network of specialized clinics. The center's methodology has been applied to various conditions, including fibromyalgia, migraines, and musculoskeletal pain.